CNS Disease as the Main Manifestation of Hemophagocytic Lymphohistiocytosis in Two Children

Abstract

Hemophagocytic lymphohistiocytosis is a rare and fatal disorder of early infancy, which affects predominantly the mononuclear phagocyte system and is characterized by the presence of fever, hepatosplenomegaly and cytopenia. Neurological symptoms can be extremely variable, ranging from irritability, and convulsions to focal neurological signs. They often develop during disease progression, but can also be the leading initial symptoms. Early diagnosis is mandatory, because new treatments, including bone marrow transplantation, appear to be promising. Here we present the clinical, neuroradiological and histopathological findings from two children with progressive CNS disease as the main clinical manifestation of hemophagocytic lymphohistiocytosis. Both children died and diagnosis was only obtained in retrospect after careful review of the histopathological material.

Key words

Hemophagocytic lymphohistiocytosis - children - neurological symptoms

References

• 1 Arico M, Danesino C, Pende D, Moretta L. Pathogenesis of haemophagocytic lymphohistiocytosis.  Br J Haematol. 2001;  114 761-769
• 2 Geldhof A B, Moser M, Lespagnard L, Thielemans K, De Baetselier P. Interleukin-12-activated natural killer cells recognize B7 costimulatory molecules on tumor cells and autologous dendritic cells.  Blood. 1998;  91 196-206
• 3 Henter J I, Elinder G, Soder O, Ost A. Incidence in Sweden and clinical features of familial hemophagocytic lymphohistiocytosis.  Acta Paediatr Scand. 1991;  80 428-435
• 4 Henter J I, Elinder G. Cerebromeningeal hemophagocytic lymphohistiocytosis.  Lancet. 1992;  1 104-107
• 5 Henter J I, Nennesmo I. Neuropathological findings and neurological symptoms in twenty-three children with hemophagocytic lymphohistiocytosis.  J Pediatrics. 1997;  130 358-365
• 6 Henter J I, Samuelsson A C, Arico M, Egeler R M, Elinder G, Filipovich A H. et al . Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immuno-chemotherapy and bone marrow transplantation.  Blood. 2002;  100 2367-2373
• 7 Janka G E. Familial hemophagocytic lymphohistiocytosis.  Eur J Pediatr. 1983;  140 221-230
• 8 Munoz Ruano M M, Castillo M. Brain CT and MR imaging in familial hemophagocytic lymphohistiocytosis.  Am J Roentgenol. 1998;  170 802
• 9 Petzold A, Thom M, Powell M, Plant G T. Relapsing intracranial Rosai-Dorfman disease.  J Neurol Neurosurg Psychiatry. 2001;  71 538-541
• 10 Risdall R J, McKenna R W, Nesbitt M E, Krivitt W, Balfour Jr H H, Simmons R L, Brunning R D. Virus-associated syndrome: a benign histiocytic proliferation distinct from malignant histiocytosis.  Cancer. 1979;  44 993-1002
• 11 Schultz Jr K D, Petronio J, Narad C, Hunter S B. Solitary intracerebral juvenile xanthogranuloma. Case report and review of the literature.  Pediatr Neurosurg. 1997;  26 315-321
• 12 Stepp S E, Dufourcq-Lagelouse R, Le Deist F, Bhawan S, Certain S. et al . Perforin gene defects in familial hemophagocytic lymphohistiocytosis.  Science. 1999;  286 1957-1959
• 13 Sumegi J, Huang D, Lanyi A, Davis J D, Seemayeeer T A, Maeda A. et al . Correlation of mutations of the SH2D1 A gene and Epstein-Barr virus infection with clinical phenotype and outcome in X-linked lymphoproliferative disease.  Blood. 2000;  96 3118-3125